AMAG
AMAG Pharmaceuticals, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Market Cap: 477 Million
Primary Exchange: NASDAQ
Website: http://www.amagpharma.com
Shares Outstanding: 34.7 Million
Float: 33.8 Million
Dividend: (%)
Beta: 1.0027584719889757
Sector: Health Technology
Industry: Pharmaceuticals: Major
Ethical Flags
Longest drawdown: 1359 trading days
From: 2015-07-16 To: 2020-11-16
Lowest Point:
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|